Wednesday’s Pre-Market Look: Stocks In The News Before The Open

Agile Therapeutics (AGRX) plummeted over 70% in after-hours trading after it said a Phase 3 study of its Twirla contraceptive patch scored a 4.8 using the Pearl Index, an index that shows the number of times the contraceptive fails over a calculated 100 years of use, worse than a competitors Pearl Index score of 3.19.

Alphabet (GOOGL) — Google’s parent company is turning its focus to India, where it will help small businesses create an online presence for free in an effort to tap into a new user population.

Amazon.com (AMZN) — The online retail giant will sell TVs from Chinese electronics maker Tongfang equipped with Amazon’s Fire TV software, giving users a range of streaming services and the ability to talk to artificial intelligence voice-activated assistant Alexa.

Athenahealth (ATHN) was upgraded to ‘Overweight’ from ‘Sector Weight’ at KeyBanc Capital Markets with a 12-month price target of $140.

Chevron (CVX) was upgraded to ‘Buy’ from ‘Neutral’ at Bank of America/Merrill Lynch.

Intuitive Surgical (ISRG) was downgraded to ‘Hold’ from ‘Buy’ at Evercore ISI with a 12-month target price of $690.

Hologic (HOLX) was downgraded to ‘Hold’ from ‘Buy’ at Evercore ISI with a 12-month target price of $42.

Priceline Group (PCLN) was initiated with a ‘Buy’ at Needham & Co. with a price target of $1,800.

Apple (AAPL) was rated a new ‘Buy’ at Guggenheim Securities with a price target of $140.

Tesla Motors (TSLA) dropped 2% in after-hours trading after it reported 76,230 vehicle deliveries for 2016, below the company’s own forecast of 80,000 vehicles.

Netgear (NTGR) was initiated at a ‘Buy’ at Guggenheim Securities with a price target of $70.

Idexx Laboratories (IDXX) gained 1% in after-hours trading when it was announced that it will replace St. Jude Medical in the S&P 500 after the close of trading on Wednesday, Jan 4.

Chemours (CC) rose over 1% in after-hours trading when it was announced that it will replace Idexx Laboratories in the S&P Midcap 400 after the close of trading on Wednesday, Jan 4.

Shake Shack (SHAK) climbed nearly 5% in after-hours trading when it was announced that it will replace Chemours in the S&P SmallCap 600 after the close of trading on Wednesday, Jan 4.

Humana (HUM) was rated a new ‘Overweight’ at Piper Jaffray with a 12-month target price of $231.

Amgen (AMGN) rose 1% in after-hours trading after a trial judge let stand a patent win on Amgen’s PCSK9 patent. Regeneron Pharmaceuticals (REGN) fell nearly 2% in after-hours trading on the news.

 

Source: FoxBusiness, CNBC, Barchart, Bloomberg, Reuters